145 related articles for article (PubMed ID: 27177600)
1. Changing trends in diagnosis, staging, treatment and survival in lung cancer: comparison of three consecutive cohorts in an Australian lung cancer centre.
Denton EJ; Hart D; Wainer Z; Wright G; Russell PA; Conron M
Intern Med J; 2016 Aug; 46(8):946-54. PubMed ID: 27177600
[TBL] [Abstract][Full Text] [Related]
2. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer in Victoria: are we making progress?
Mitchell PL; Thursfield VJ; Ball DL; Richardson GE; Irving LB; Torn-Broers Y; Giles GG; Wright GM
Med J Aust; 2013 Nov; 199(10):674-9. PubMed ID: 24237097
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
6. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
[TBL] [Abstract][Full Text] [Related]
7. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
8. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer outcomes at a UK cancer unit between 1998-2001.
Free CM; Ellis M; Beggs L; Beggs D; Morgan SA; Baldwin DR
Lung Cancer; 2007 Aug; 57(2):222-8. PubMed ID: 17442450
[TBL] [Abstract][Full Text] [Related]
10. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
11. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
[TBL] [Abstract][Full Text] [Related]
12. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
[TBL] [Abstract][Full Text] [Related]
13. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
14. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
[TBL] [Abstract][Full Text] [Related]
16. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
17. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
[TBL] [Abstract][Full Text] [Related]
19. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.
Koumarianou A; Fountzilas G; Kosmidis P; Klouvas G; Samantas E; Kalofonos C; Pentheroudakis G; Economopoulos T; Pectasides D
J Chemother; 2009 Nov; 21(5):573-83. PubMed ID: 19933050
[TBL] [Abstract][Full Text] [Related]
20. Gaps in optimal care for lung cancer.
Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]